FDA launches real-time clinical trials to speed up drug development
Two proof-of-concept trials now report data directly to regulators as studies progress, with broader pilot program coming this summer
OpenAI launches GPT-Rosalind AI model for life sciences research
New model named after DNA pioneer aims to speed up drug discovery and biochemistry research
Amazon launches nationwide weight-loss program with GLP-1 drugs
The retail giant integrates popular diabetes and weight-loss medications into its healthcare services with transparent pricing and delivery
AI medical scribes get smart glasses upgrade for better patient notes
Vision-enabled AI scribes achieve 98% accuracy compared to 81% for audio-only systems
Anthropic buys AI biotech startup Coefficient Bio for $400 million
The deal brings drug discovery expertise to the Claude maker as it expands into healthcare
Insilico Medicine partners with Eli Lilly in $2.75 billion AI drug discovery deal
The collaboration combines AI-driven drug discovery with Lilly's clinical development expertise across multiple diseases
Samsung’s new Hearapy app fights motion sickness with sound waves
The free mobile app plays a specific 100 Hz tone that could prevent car sickness for up to two hours
Roche builds massive AI supercomputer with 3,500 NVIDIA GPUs for drug discovery
Swiss pharmaceutical giant deploys what it calls the largest GPU infrastructure available to any pharma company
Persistent Systems partners with NVIDIA to speed up drug discovery with AI
The collaboration uses NVIDIA's BioNeMo platform to create virtual drug screening tools that could reduce research timelines from months to days
Diathrive Health, Mark Cuban Cost Plus Drug Company to improve access to low-cost drugs
The relationship will give consumers lower-cost medications and diabetes testing supplies and more personalized, higher-quality care